Skip to main content

Woodline Partners LP

Position in ELVN — Enliven Therapeutics, Inc.

CIK 1784547 San Francisco, CA

Position in ELVN

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$17,617,456
+$5,791,875 QoQ
Shares Held
347,142
+15.1% QoQ
Ownership
0.474%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
#46
of 208 holders
Holding Since
Sep 2023
12 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in ELVN Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Woodline Partners LP holds $4,400,572,274 across 197 Biotechnology names. ELVN ranks #67 (0.4% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in ELVN

Export CSV
12 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $17,617,456 347,142
2026-03-31 $11,825,581 301,673
2025-12-31 $4,635,754 301,023
2025-09-30 $6,151,214 300,499
2025-06-30 $22,079,179 1,100,657
2025-03-31 $15,845,489 805,157
2024-12-31 $18,133,245 805,922
2024-09-30 $20,590,015 806,187
2024-06-30 $16,884,918 722,504
2024-03-31 $6,960,116 395,686
2023-12-31 $5,476,294 395,686
2023-09-30 $5,405,070 395,686